#Oncomastodon In high-risk #Hodgkinslymphoma, brentuximab vedotin in combination with #chemotherapy has shown greater efficacy than chemotherapy alone, but at the cost of increased toxic effects.
https://www.nejm.org/doi/pdf/10.1056/NEJMoa2206660?articleTools=true
https://www.nejm.org/do/10.1056/NEJMdo006741/full/
@NEJM